AAPS Pharmscitech

Papers
(The H4-Index of AAPS Pharmscitech is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation219
3D Printing as a Promising Tool in Personalized Medicine166
Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology76
Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations65
3D Printing Technologies: Recent Development and Emerging Applications in Various Drug Delivery Systems54
Digital Pharmaceutical Sciences51
Combined Therapy for Alzheimer’s Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity48
3D Printing: Applications in Tissue Engineering, Medical Devices, and Drug Delivery46
Formulation Optimization of Selective Laser Sintering 3D-Printed Tablets of Clindamycin Palmitate Hydrochloride by Response Surface Methodology44
Polyvinyl Alcohol/Chitosan Single-Layered and Polyvinyl Alcohol/Chitosan/Eudragit RL100 Multi-layered Electrospun Nanofibers as an Ocular Matrix for the Controlled Release of Ofloxacin: an In Vitro an43
Fabrication of Taste-Masked Donut-Shaped Tablets Via Fused Filament Fabrication 3D Printing Paired with Hot-Melt Extrusion Techniques43
Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration41
Formulation Development, Characterization, and Evaluation of a Novel Dexibuprofen-Capsaicin Skin Emulgel with Improved In Vivo Anti-inflammatory and Analgesic Effects39
Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment39
Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations38
Nanodelivery of Resveratrol-Loaded PLGA Nanoparticles for Age-Related Macular Degeneration38
RETRACTED ARTICLE: Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluati37
EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer36
Biomaterials for Tissue Engineering Applications and Current Updates in the Field: A Comprehensive Review36
Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy35
Emerging Trends in Topical Delivery of Curcumin Through Lipid Nanocarriers: Effectiveness in Skin Disorders34
Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment34
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents33
Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics33
Fabrication of Highly Deformable Bilosomes for Enhancing the Topical Delivery of Terconazole: In Vitro Characterization, Microbiological Evaluation, and In Vivo Skin Deposition Study31
Lyophilization of Small-Molecule Injectables: an Industry Perspective on Formulation Development, Process Optimization, Scale-Up Challenges, and Drug Product Quality Attributes31
Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy30
Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-1930
Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions30
Biosynthesis, Characterization, and Wound-Healing Activity of Phenytoin-Loaded Copper Nanoparticles30
Transdermal Delivery of Curcumin-Loaded Solid Lipid Nanoparticles as Microneedle Patch: an In Vitro and In Vivo Study30
Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment30
0.037312984466553